Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 12:51 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2305–2328 of 2,496 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Spinal Clear all

Conditions: Chronic Pain
Interventions: Standard of care neuromodulation therapy (SCS or DRG); Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Chronic Pain, Back Pain
Interventions: Boston Scientific Spectra WaveWriter™ Spinal Cord Stimulation (SCS) System; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 22 Years and older
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 15
States / cities: Phoenix, Arizona • La Jolla, California • Greenwood Village, Colorado + 12 more

Conditions: Neurogenic Bladder, Urinary Retention, Urologic Diseases
Interventions: Connected Catheter; Device
Lead sponsor: Spinal Singularity; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 3
States / cities: Downey, California • San Diego, California • Washington D.C., District of Columbia

Conditions: Spinal Cord Injuries
Interventions: Structured Interview; Other
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 80 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Spinal Anesthesia, Epidural; Anesthesia
Interventions: 10 mg Bupivacaine, 5 mg Bupivacaine; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Musculoskeletal Manipulations
Interventions: Spinal Manual Therapy, Spinal Range of Motion; Procedure
Lead sponsor: Shenandoah University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Winchester, Virginia

Conditions: Osteoarthritis, Hip
Interventions: isobaric bupivacaine, hyperbaric bupivacaine, isobaric mepivacaine; Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 84 Years
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 2
States / cities: Bensalem, Pennsylvania • Philadelphia, Pennsylvania

Conditions: Anesthesia, Local
Interventions: Dose adjustment of bupivacaine; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Spinal Cord Injuries, Slow Breathing
Interventions: Slow Breathing; Behavioral
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 18 Years to 60 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Mixed Phenotype Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia
Interventions: Dasatinib, Methotrexate, Prednisone, Rituximab, Venetoclax, Blinatumomab, Bone Marrow Aspiration and Biopsy, Lumbar Puncture, Biospecimen Collection; Drug · Biological · Procedure
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Spinal Cord Injury Cervical
Interventions: Access-H2O faucet; Device
Lead sponsor: Old Dominion University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Central Nervous System Tumor
Interventions: Not listed
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: Not listed
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Proximal Junctional Kyphosis, Adult Spinal Deformity Surgery, Thoracolumbosacral Orthosis
Interventions: Align PJK™ TLSO brace, Standard of Care; Device · Other
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 30 Years to 75 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 6
States / cities: Carmel, Indiana • Overland Park, Kansas • New York, New York + 3 more

Conditions: Spinal Cord Injuries
Interventions: Seated control (CON), Moderate intensity continuous (MICT), High intensity interval training (HIIT), Circuit resistance training (CRT), Liquid Meal; Behavioral · Other
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Spinal Cord Injury
Interventions: Indego Exoskeleton; Device
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 3
States / cities: Tampa, Florida • Rochester, Minnesota • Nashville, Tennessee

Conditions: Spinal Cord Injury
Interventions: Exoskeleton-Assisted Walking (EAW), Sham Transcutaneous Spinal Cord Stimulation (tSCS), Active Transcutaneous Spinal Cord Stimulation (tSCS); Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years to 60 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 2
States / cities: West Orange, New Jersey • The Bronx, New York

Conditions: Brain Tumor, Pediatric Brain Tumor, Pediatric Cancer
Interventions: Diffusion tensor imaging (DTI), Resting state functional connectivity MRI (rs-fcMRI), Wechsler Intelligence Scale for Children - 5th edition (WISC-V), California Verbal Learning Test (CVLT-C), Beery Test of Visual Motor Integration 6th edition, Grooved Pegboard, PedsQL Multidimensional Fatigue Scale, MRI; Diagnostic Test · Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 6 Years to 16 Years
Enrollment: 42 participants
Timeline: 2017 – 2027
U.S. locations: 4
States / cities: New York, New York • Dallas, Texas • Seattle, Washington

Conditions: Adolescent Idiopathic Scoliosis
Interventions: Momentum Application; Device
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 8 Years to 18 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Osteoporosis, Bone Loss, Spinal Cord Injury
Interventions: teriparatide, weight-bearing; Drug · Other
Lead sponsor: Thomas J. Schnitzer; Other
Eligibility: 18 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Degenerative Disc Disease
Interventions: DEXA-C Cervical Interbody System; Device
Lead sponsor: Aurora Spine and Pain; Industry
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 4
States / cities: Orange, California • Paducah, Kentucky • Covington, Louisiana + 1 more

Conditions: Degenerative Spine Disease, Spinal Deformity
Interventions: Not listed
Lead sponsor: Mazor Robotics; Industry
Eligibility: 6 Years to 90 Years
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 4
States / cities: Jacksonville, Florida • Memphis, Tennessee • Houston, Texas + 1 more

Conditions: Spinal Cord Injury
Interventions: HP184; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 262 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Osteopathic Manipulative Treatment (OMT) Effects on Cerebrospinal Fluid (CSF) Dynamics
Interventions: Osteopathic Manipulative Treatment (OMT); Other
Lead sponsor: Edward Via Virginia College of Osteopathic Medicine; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Lumbar Spinal Stenosis
Interventions: Physical therapy intervention; Other
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 50 Years to 89 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Amarillo, Texas

Search by objective public record fields.

External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO)

Combining Mechanisms for Better Outcomes (COMBO)

Connected Catheter - Safety and Effectiveness Study

Resilience in Persons Following Spinal Cord Injury

Bupivacaine With Epidural Volume Extension

The Effect of Thoracic Spine Manipulation on Peripheral Neurodynamic Mobility

3 Local Anesthetics for Spinal Anesthesia in Primary Total Hip Arthroplasty

ED50 and ED95 of Isobaric Bupivacaine for Post-Partum Bilateral Tubal Ligation

Slow Yogic-Derived Breathing and Respiration and Cardiovascular Variability in Spinal Cord Injury Patients

Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia

Access-H20 Faucet for Spinal Cord Injury

Tissue Collection for Drug Screening and Bioanalysis

Post-Operative Thoracolumosacral Orthosis for PJK

Energetic Response to Feeding and Exercise in SCI

Mobility and Therapeutic Benefits Resulting From Exoskeleton Use in a Clinical Setting (SC140121 Study 1 and 2)

Exoskeletal-assisted Walking Combined With Transcutaneous Spinal Cord Stimulation: Effect on Imaging and Serum Biomarkers of Skeletal Muscle Mass and Bone Strength.

Understanding the Late Effects of Surviving a Pediatric Brain Tumor

Detecting and Monitoring Scoliosis Without Radiography: Standard Radiographic Monitoring Program Versus Self-Screening With Momentum SpineTM

Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)

Investigation of DEXA-C Anterior Cervical Interbody System

Prospective, Observational Registry of Renaissance-guided Spine Surgeries

HP184 in Chronic Spinal Cord Injury Subjects

Exploring How Osteopathic Manipulative Treatment May Affect Spinal Fluid Flow: An MRI Study

Physical Therapy Treatments, Including Neural Mobilization and Hip/Back Stretches for People Between 50-89 With Lumbar Spinal Stenosis and Leg Pain Provoked by Walking